Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_assertion type Assertion NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_head.
- NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_assertion description "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_provenance.
- NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_assertion evidence source_evidence_literature NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_provenance.
- NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_assertion SIO_000772 22562245 NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_provenance.
- NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_assertion wasDerivedFrom befree-2016 NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_provenance.
- NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_assertion wasGeneratedBy ECO_0000203 NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_provenance.